Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Animal Models of Psychosis in Alzheimer Disease.

Krivinko JM, Koppel J, Savonenko A, Sweet RA.

Am J Geriatr Psychiatry. 2019 May 17. pii: S1064-7481(19)30364-1. doi: 10.1016/j.jagp.2019.05.009. [Epub ahead of print] Review.

PMID:
31278012
2.

Regulatory roles of IL-10-producing human follicular T cells.

Cañete PF, Sweet RA, Gonzalez-Figueroa P, Papa I, Ohkura N, Bolton H, Roco JA, Cuenca M, Bassett KJ, Sayin I, Barry E, Lopez A, Canaday DH, Meyer-Hermann M, Doglioni C, Fazekas de St Groth B, Sakaguchi S, Cook MC, Vinuesa CG.

J Exp Med. 2019 Aug 5;216(8):1843-1856. doi: 10.1084/jem.20190493. Epub 2019 Jun 17.

3.

Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.

Wang L, Ying J, Fan P, Weamer EA, DeMichele-Sweet MAA, Lopez OL, Kofler JK, Sweet RA.

Am J Geriatr Psychiatry. 2019 Sep;27(9):908-917. doi: 10.1016/j.jagp.2019.03.016. Epub 2019 Mar 27.

PMID:
31126722
4.

Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia.

Nucifora LG, MacDonald ML, Lee BJ, Peters ME, Norris AL, Orsburn BC, Yang K, Gleason K, Margolis RL, Pevsner J, Tamminga CA, Sweet RA, Ross CA, Sawa A, Nucifora FC Jr.

Am J Psychiatry. 2019 May 6:appiajp201918070864. doi: 10.1176/appi.ajp.2019.18070864. [Epub ahead of print]

PMID:
31055969
5.

Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease.

DeMichele-Sweet MAA, Weamer EA, Klei L, Vrana DT, Hollingshead DJ, Seltman HJ, Sims R, Foroud T, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Ruiz A, Williams J, Mayeux R, Lopez OL, Sibille EL, Kamboh MI, Devlin B, Sweet RA.

Mol Psychiatry. 2019 Mar 12. doi: 10.1038/s41380-019-0373-9. [Epub ahead of print]

PMID:
30862939
6.

Density of small dendritic spines and microtubule-associated-protein-2 immunoreactivity in the primary auditory cortex of subjects with schizophrenia.

McKinney BC, MacDonald ML, Newman JT, Shelton MA, DeGiosio RA, Kelly RM, Fish KN, Sampson AR, Lewis DA, Sweet RA.

Neuropsychopharmacology. 2019 May;44(6):1055-1061. doi: 10.1038/s41386-019-0350-7. Epub 2019 Feb 22.

PMID:
30795003
7.

Laser capture microdissection-targeted mass spectrometry: a method for multiplexed protein quantification within individual layers of the cerebral cortex.

MacDonald ML, Favo D, Garver M, Sun Z, Arion D, Ding Y, Yates N, Sweet RA, Lewis DA.

Neuropsychopharmacology. 2019 Mar;44(4):743-748. doi: 10.1038/s41386-018-0260-0. Epub 2018 Nov 2.

PMID:
30390066
8.

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease.

Hu Z, Wang L, Ma S, Kirisci L, Feng Z, Xue Y, Klunk WE, Kamboh MI, Sweet RA, Becker J, Lv Q, Lopez OL, Xie XQ.

Alzheimers Dement (N Y). 2018 Oct 14;4:542-555. doi: 10.1016/j.trci.2018.09.001. eCollection 2018.

9.

Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.

Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C, Burns J, Quinn J, Sweet RA, Rascovsky K, Teylan M, Beekly D, Thomas G, Bollenbeck M, Monsell S, Mock C, Zhou XH, Thomas N, Robichaud E, Dean M, Hubbard J, Jacka M, Schwabe-Fry K, Wu J, Phelps C, Morris JC; Neuropsychology Work Group, Directors, and Clinical Core leaders of the National Institute on Aging-funded US Alzheimer’s Disease Centers.

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358. doi: 10.1097/WAD.0000000000000279.

10.

Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.

Krivinko JM, Erickson SL, Ding Y, Sun Z, Penzes P, MacDonald ML, Yates NA, Ikonomovic MD, Lopez OL, Sweet RA, Kofler J.

Am J Psychiatry. 2018 Oct 1;175(10):999-1009. doi: 10.1176/appi.ajp.2018.17080858. Epub 2018 Jul 19.

PMID:
30021459
12.

Stereological Assessments of Neuronal Pathology in Auditory Cortex in Schizophrenia.

Parker EM, Sweet RA.

Front Neuroanat. 2018 Jan 9;11:131. doi: 10.3389/fnana.2017.00131. eCollection 2017. Review.

13.

A Schizophrenia-Linked KALRN Coding Variant Alters Neuron Morphology, Protein Function, and Transcript Stability.

Russell TA, Grubisha MJ, Remmers CL, Kang SK, Forrest MP, Smith KR, Kopeikina KJ, Gao R, Sweet RA, Penzes P.

Biol Psychiatry. 2018 Mar 15;83(6):499-508. doi: 10.1016/j.biopsych.2017.10.024. Epub 2017 Nov 7.

14.

A putative electrophysiological biomarker of auditory sensory memory encoding is sensitive to pharmacological alterations of excitatory/inhibitory balance in male macaque monkeys.

Holliday WB, Gurnsey K, Sweet RA, Teichert T.

J Psychiatry Neurosci. 2017 Dec 13;43(1):170093. doi: 10.1503/jpn.170093. [Epub ahead of print]

PMID:
29236648
15.

DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia.

McKinney BC, Lin H, Ding Y, Lewis DA, Sweet RA.

Schizophr Res. 2018 Jun;196:39-44. doi: 10.1016/j.schres.2017.09.025. Epub 2017 Oct 5.

16.

TFH-derived dopamine accelerates productive synapses in germinal centres.

Papa I, Saliba D, Ponzoni M, Bustamante S, Canete PF, Gonzalez-Figueroa P, McNamara HA, Valvo S, Grimbaldeston M, Sweet RA, Vohra H, Cockburn IA, Meyer-Hermann M, Dustin ML, Doglioni C, Vinuesa CG.

Nature. 2017 Jul 20;547(7663):318-323. doi: 10.1038/nature23013. Epub 2017 Jul 12.

17.

B Cell-Extrinsic Myd88 and Fcer1g Negatively Regulate Autoreactive and Normal B Cell Immune Responses.

Sweet RA, Nickerson KM, Cullen JL, Wang Y, Shlomchik MJ.

J Immunol. 2017 Aug 1;199(3):885-893. doi: 10.4049/jimmunol.1600861. Epub 2017 Jun 28.

18.

DNA methylation evidence against the accelerated aging hypothesis of schizophrenia.

McKinney BC, Lin H, Ding Y, Lewis DA, Sweet RA.

NPJ Schizophr. 2017 Mar 23;3:13. doi: 10.1038/s41537-017-0017-5. eCollection 2017.

19.

Genetic risk for schizophrenia and psychosis in Alzheimer disease.

DeMichele-Sweet MAA, Weamer EA, Klei L, Vrana DT, Hollingshead DJ, Seltman HJ, Sims R, Foroud T, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Ruiz A, Williams J, Mayeux R, Lopez OL, Sibille EL, Kamboh MI, Devlin B, Sweet RA.

Mol Psychiatry. 2018 Apr;23(4):963-972. doi: 10.1038/mp.2017.81. Epub 2017 May 2. Erratum in: Mol Psychiatry. 2019 Mar 12;:.

20.

Selective Loss of Smaller Spines in Schizophrenia.

MacDonald ML, Alhassan J, Newman JT, Richard M, Gu H, Kelly RM, Sampson AR, Fish KN, Penzes P, Wills ZP, Lewis DA, Sweet RA.

Am J Psychiatry. 2017 Jun 1;174(6):586-594. doi: 10.1176/appi.ajp.2017.16070814. Epub 2017 Mar 31.

21.

Kalirin reduction rescues psychosis-associated behavioral deficits in APPswe/PSEN1dE9 transgenic mice.

Krivinko JM, Erickson SL, Abrahamson EE, Wills ZP, Ikonomovic MD, Penzes P, Sweet RA.

Neurobiol Aging. 2017 Jun;54:59-70. doi: 10.1016/j.neurobiolaging.2017.02.006. Epub 2017 Feb 16.

22.

Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease.

Mi Z, Abrahamson EE, Ryu AY, Fish KN, Sweet RA, Mufson EJ, Ikonomovic MD.

Neurobiol Aging. 2017 Jul;55:159-166. doi: 10.1016/j.neurobiolaging.2017.01.022. Epub 2017 Feb 4.

23.

Polygenic risk scores in familial Alzheimer disease.

Tosto G, Bird TD, Tsuang D, Bennett DA, Boeve BF, Cruchaga C, Faber K, Foroud TM, Farlow M, Goate AM, Bertlesen S, Graff-Radford NR, Medrano M, Lantigua R, Manly J, Ottman R, Rosenberg R, Schaid DJ, Schupf N, Stern Y, Sweet RA, Mayeux R.

Neurology. 2017 Mar 21;88(12):1180-1186. doi: 10.1212/WNL.0000000000003734. Epub 2017 Feb 17.

24.

DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia.

McKinney B, Ding Y, Lewis DA, Sweet RA.

Transl Psychiatry. 2017 Feb 14;7(2):e1032. doi: 10.1038/tp.2016.297.

25.

Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.

Weamer EA, DeMichele-Sweet MA, Cloonan YK, Lopez OL, Sweet RA.

J Clin Psychiatry. 2016 Dec;77(12):e1564-e1569. doi: 10.4088/JCP.15m10617.

26.

Contextual processing in unpredictable auditory environments: the limited resource model of auditory refractoriness in the rhesus.

Teichert T, Gurnsey K, Salisbury D, Sweet RA.

J Neurophysiol. 2016 Nov 1;116(5):2125-2139. doi: 10.1152/jn.00419.2016. Epub 2016 Aug 10.

27.

The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.

Tosto G, Bird TD, Bennett DA, Boeve BF, Brickman AM, Cruchaga C, Faber K, Foroud TM, Farlow M, Goate AM, Graff-Radford NR, Lantigua R, Manly J, Ottman R, Rosenberg R, Schaid DJ, Schupf N, Stern Y, Sweet RA, Mayeux R; National Institute on Aging Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) Family Study Group.

JAMA Neurol. 2016 Oct 1;73(10):1231-1237. doi: 10.1001/jamaneurol.2016.2539.

28.

Age-dependent increase in Kalirin-9 and Kalirin-12 transcripts in human orbitofrontal cortex.

Grubisha MJ, Lin CW, Tseng GC, Penzes P, Sibille E, Sweet RA.

Eur J Neurosci. 2016 Oct;44(7):2483-2492. doi: 10.1111/ejn.13351. Epub 2016 Aug 18.

29.

Schizophrenia interactome with 504 novel protein-protein interactions.

Ganapathiraju MK, Thahir M, Handen A, Sarkar SN, Sweet RA, Nimgaonkar VL, Loscher CE, Bauer EM, Chaparala S.

NPJ Schizophr. 2016 Apr 27;2:16012. doi: 10.1038/npjschz.2016.12. eCollection 2016.

30.

Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease.

Sweet RA, MacDonald ML, Kirkwood CM, Ding Y, Schempf T, Jones-Laughner J, Kofler J, Ikonomovic MD, Lopez OL, Garver ME, Fitz NF, Koldamova R, Yates NA.

Mol Cell Proteomics. 2016 Jul;15(7):2252-62. doi: 10.1074/mcp.M115.056580. Epub 2016 Apr 21.

31.

FastGGM: An Efficient Algorithm for the Inference of Gaussian Graphical Model in Biological Networks.

Wang T, Ren Z, Ding Y, Fang Z, Sun Z, MacDonald ML, Sweet RA, Wang J, Chen W.

PLoS Comput Biol. 2016 Feb 12;12(2):e1004755. doi: 10.1371/journal.pcbi.1004755. eCollection 2016 Feb.

32.

Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration.

Kirkwood CM, MacDonald ML, Schempf TA, Vatsavayi AV, Ikonomovic MD, Koppel JL, Ding Y, Sun M, Kofler JK, Lopez OL, Yates NA, Sweet RA.

J Neuropathol Exp Neurol. 2016 Feb;75(2):175-82.

33.

Genetics of psychosis of Alzheimer disease.

Shah C, DeMichele-Sweet MA, Sweet RA.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):27-35. doi: 10.1002/ajmg.b.32413. Epub 2016 Jan 12. Review.

34.

Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation.

Ramiscal RR, Parish IA, Lee-Young RS, Babon JJ, Blagih J, Pratama A, Martin J, Hawley N, Cappello JY, Nieto PF, Ellyard JI, Kershaw NJ, Sweet RA, Goodnow CC, Jones RG, Febbraio MA, Vinuesa CG, Athanasopoulos V.

Elife. 2015 Oct 23;4. pii: e08698. doi: 10.7554/eLife.08698.

35.

Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families.

Barral S, Vardarajan BN, Reyes-Dumeyer D, Faber KM, Bird TD, Tsuang D, Bennett DA, Rosenberg R, Boeve BF, Graff-Radford NR, Goate AM, Farlow M, Lantigua R, Medrano MZ, Wang X, Kamboh MI, Barmada MM, Schaid DJ, Foroud TM, Weamer EA, Ottman R, Sweet RA, Mayeux R; NIA-LOAD/NCRAD Family Study Group.

Neurobiol Aging. 2015 Nov;36(11):3116.e9-3116.e16. doi: 10.1016/j.neurobiolaging.2015.08.006. Epub 2015 Aug 15.

36.

Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Javitt DC, Sweet RA.

Nat Rev Neurosci. 2015 Sep;16(9):535-50. doi: 10.1038/nrn4002. Review.

37.

A Bayesian model of psychosis symptom trajectory in Alzheimer's disease.

Seltman HJ, Mitchell S, Sweet RA.

Int J Geriatr Psychiatry. 2016 Feb;31(2):204-10. doi: 10.1002/gps.4326. Epub 2015 Jul 27.

38.

More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.

Rosenthal SL, Bamne MN, Wang X, Berman S, Snitz BE, Klunk WE, Sweet RA, Demirci FY, Lopez OL, Kamboh MI.

Neurobiol Aging. 2015 Aug;36(8):2443.e21-6. doi: 10.1016/j.neurobiolaging.2015.04.012. Epub 2015 Apr 25.

39.

Genome-wide copy-number variation study of psychosis in Alzheimer's disease.

Zheng X, Demirci FY, Barmada MM, Richardson GA, Lopez OL, Sweet RA, Kamboh MI, Feingold E.

Transl Psychiatry. 2015 Jun 2;5:e574. doi: 10.1038/tp.2015.64.

40.

GABA-Synthesizing Enzymes in Calbindin and Calretinin Neurons in Monkey Prefrontal Cortex.

Rocco BR, Sweet RA, Lewis DA, Fish KN.

Cereb Cortex. 2016 May;26(5):2191-2204. doi: 10.1093/cercor/bhv051. Epub 2015 Mar 30.

41.

Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Shelton MA, Newman JT, Gu H, Sampson AR, Fish KN, MacDonald ML, Moyer CE, DiBitetto JV, Dorph-Petersen KA, Penzes P, Lewis DA, Sweet RA.

Biol Psychiatry. 2015 Sep 15;78(6):374-85. doi: 10.1016/j.biopsych.2014.12.029. Epub 2015 Jan 30.

42.

VSNL1 Co-Expression Networks in Aging Include Calcium Signaling, Synaptic Plasticity, and Alzheimer's Disease Pathways.

Lin CW, Chang LC, Tseng GC, Kirkwood CM, Sibille EL, Sweet RA.

Front Psychiatry. 2015 Mar 9;6:30. doi: 10.3389/fpsyt.2015.00030. eCollection 2015.

43.

Developmental Trajectories of Auditory Cortex Synaptic Structures and Gap-Prepulse Inhibition of Acoustic Startle Between Early Adolescence and Young Adulthood in Mice.

Moyer CE, Erickson SL, Fish KN, Thiels E, Penzes P, Sweet RA.

Cereb Cortex. 2016 May;26(5):2115-26. doi: 10.1093/cercor/bhv040. Epub 2015 Mar 10.

44.

Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.

Wang X, Lopez O, Sweet RA, Becker JT, DeKosky ST, Barmada MM, Feingold E, Demirci FY, Kamboh MI.

J Alzheimers Dis. 2015;45(2):651-8.

45.

Dendritic spine alterations in schizophrenia.

Moyer CE, Shelton MA, Sweet RA.

Neurosci Lett. 2015 Aug 5;601:46-53. doi: 10.1016/j.neulet.2014.11.042. Epub 2014 Dec 3. Review.

46.

Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia.

MacDonald ML, Ding Y, Newman J, Hemby S, Penzes P, Lewis DA, Yates NA, Sweet RA.

Biol Psychiatry. 2015 Jun 1;77(11):959-68. doi: 10.1016/j.biopsych.2014.09.006. Epub 2014 Nov 26.

47.

A rare duplication on chromosome 16p11.2 is identified in patients with psychosis in Alzheimer's disease.

Zheng X, Demirci FY, Barmada MM, Richardson GA, Lopez OL, Sweet RA, Kamboh MI, Feingold E.

PLoS One. 2014 Nov 7;9(11):e111462. doi: 10.1371/journal.pone.0111462. eCollection 2014.

48.

The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Hu W, MacDonald ML, Elswick DE, Sweet RA.

Ann N Y Acad Sci. 2015 Mar;1338:38-57. doi: 10.1111/nyas.12547. Epub 2014 Oct 14. Review.

49.

A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness.

Russell TA, Blizinsky KD, Cobia DJ, Cahill ME, Xie Z, Sweet RA, Duan J, Gejman PV, Wang L, Csernansky JG, Penzes P.

Nat Commun. 2014 Sep 16;5:4858. doi: 10.1038/ncomms5858.

50.

Genetic determinants of disease progression in Alzheimer's disease.

Wang X, Lopez OL, Sweet RA, Becker JT, DeKosky ST, Barmada MM, Demirci FY, Kamboh MI.

J Alzheimers Dis. 2015;43(2):649-55. doi: 10.3233/JAD-140729.

Supplemental Content

Loading ...
Support Center